Vietnam Healthcare Sector
Pharmaceuticals, Medical Devices, and Digital Health in Vietnam
Vietnam’s healthcare spending reached 6–7 billion in 2023 and projected to reach up to $14 billion by 2033.
While there are 243 GMP-WHO factories in Vietnam, they mostly produce generics, meeting only 46% of market value. High-margin patented medicines and specialized treatments for chronic diseases remain dominated by imports. Similarly, 90% of medical devices are imported, with the market expected to reach $2.1–3 billion by 2026.
The government is actively upgrading provincial hospitals, creating a high demand for MRI, CT scanners, and lab diagnostics. Digital health is also gaining traction; telemedicine and electronic medical records are expanding under the government’s digital transformation strategy. Foreign firms must navigate a complex landscape of MOH registrations and hospital tenders, where after-sales service and clinician training are often the deciding factors for success.
Our Healthcare sector coverage
-
Pharmaceuticals
-
Medical devices
-
Medical consumables and disposables
-
Diagnostics and laboratory systems
-
Digital health and healthcare IT
-
Life sciences and biotechnology
